Alex Janin

Shares of Viking Therapeutics surged roughly 30% Tuesday morning after the company reported its experimental weight-loss shot could help people keep the weight off at less-frequent doses. The move put the stock on pace for its biggest one-day percentage gain since February 2024. In the study, patie

A drug combination studied in people with Type 2 diabetes lowered blood sugar and helped people lose more weight than with Zepbound alone.

Drugmakers are targeting muscle preservation and fat loss as they build the next generation of weight-loss medications.

For as long as drugmakers have been testing weight-loss drugs, the question has been: How much weight do people lose? Now it is changing to: What kind of weight are they losing?

U.S. states’ methods for obtaining the drugs used in carrying out executions are shrouded in secrecy.

Tennessee's failed execution of Christa Pike this week has resulted in fresh scrutiny of the shaky and secretive supply chain for lethal injection drugs.

Johnson & Johnson is “leaning” toward spinning out the hips-and-knees business that the company has been looking to hive off, Chief Financial Officer Joseph Wolk said.

Shares of Johnson & Johnson dropped more than 5% Tuesday morning after the company reported weaker-than-expected results from its medical devices division. “We are clear on where MedTech performance needs to improve,” said J&J’s chief financial officer Joe Wolk on the earnings call, citing its card

Johnson & Johnson is “leaning” toward spinning out the hips-and-knees business that the company has been looking to hive off, Chief Financial Officer Joseph Wolk said.

A patient in Bristol Myers Squibb’s multiple sclerosis study died after taking its experimental cell therapy, the company said Friday. The stock fell 2.4%. The patient who died started having movement-related problems after receiving the infusion and died 44 days after receiving the drug, the compa